Monday, September 27, 2021  | 19 Safar, 1443
Samaa TV
Facebook Twitter Youtube
HOME > Health

Moderna says its Covid-19 vaccine ‘highly effective’ in teens

Vaccine-maker will apply for FDA authorisation in June

SAMAA | - Posted: May 25, 2021 | Last Updated: 4 months ago
SAMAA |
Posted: May 25, 2021 | Last Updated: 4 months ago

Photo: AFP

Listen to the story
US biotech firm Moderna said Tuesday that trials had shown its Covid-19 vaccine is "highly effective" in adolescents aged 12-17 and the company would seek regulators' approval in June. This study, known as the TeenCOVE study, enrolled more than 3,700 participants ages 12 to less than 18 years in the US. "We are encouraged that mRNA-1273 was highly effective at preventing Covid-19 in adolescents," CEO Stephane Bancel said in a statement. "We will submit these results to the US FDA and regulators globally in early June and request authorization." Research by US scientists has shown that the Pfizer and Moderna Covid vaccines should remain highly effective against two coronavirus variants first identified in India. The lab-based study was carried out by the NYU Grossman School of Medicine and NYU Langone Center and is considered preliminary because it has not yet been published in a peer-reviewed journal. "What we found is that the vaccine's antibodies are a little bit weaker against the variants, but not enough that we think it would have much of an effect on the protective ability of the vaccines," senior author Nathaniel "Ned" Landau told AFP.
FaceBook WhatsApp

US biotech firm Moderna said Tuesday that trials had shown its Covid-19 vaccine is “highly effective” in adolescents aged 12-17 and the company would seek regulators’ approval in June.

This study, known as the TeenCOVE study, enrolled more than 3,700 participants ages 12 to less than 18 years in the US.

“We are encouraged that mRNA-1273 was highly effective at preventing Covid-19 in adolescents,” CEO Stephane Bancel said in a statement.

“We will submit these results to the US FDA and regulators globally in early June and request authorization.”

Research by US scientists has shown that the Pfizer and Moderna Covid vaccines should remain highly effective against two coronavirus variants first identified in India.

The lab-based study was carried out by the NYU Grossman School of Medicine and NYU Langone Center and is considered preliminary because it has not yet been published in a peer-reviewed journal.

“What we found is that the vaccine’s antibodies are a little bit weaker against the variants, but not enough that we think it would have much of an effect on the protective ability of the vaccines,” senior author Nathaniel “Ned” Landau told AFP.

 
HOME  
 
 
RELATED STORIES

Tell us what you think:

Your email address will not be published.

FaceBook WhatsApp
 
 
 
moderna covid vaccine, vaccine maker moderna, coronavirus vaccines, covid vaccine for children, covid vaccine for teenagers, moderna vaccine side effects, moderna vaccine country, moderna vaccine vs pfizer, moderna vaccine manufacturer, moderna vaccine second dose, moderna vaccine side effects first dose, where is moderna vaccine made, moderna vaccine hotline, samaa news, samaa health, samaa tv live
 
 
 
 
 
 
About Us   |   Anchor Profiles   |   Online Advertising   |   Contact Us   |   Feedback   |   Apps   |   FAQs   |   Authors   |   Comment Policy
Facebook   |   Twitter   |   Instagram   |   YouTube   |   WhatsApp